🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aim 1: Expand and adapt the CARE framework to train providers to cultivate ...
Status
Active Not Recruiting
Location
Unmute Enterprise Inc. [A telehealth company]
Start Date
2025-09-15
Trial ID
NCT06625502
Treatments Being Tested
The main purpose of this study is to characterize the single-dose pharmacok...
Status
Completed
Location
Celerion
Start Date
2017-04-20
Trial ID
NCT03127189
Treatments Being Tested
The aim of the study is to compare how different formulations of AZD0530 ar...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00771979
The primary objective of this study is to evaluate the effects of a formula...
Status
Completed
Location
ASST Gaetano Pini CTO, UOC Clinica Reumatologica
Start Date
2025-05-16
Trial ID
NCT06990152
Treatments Being Tested
This study is a multicenter, open-label study of polatuzumab vedotin admini...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-10-15
Trial ID
NCT02257567
Background: Practical and psychological barriers make it difficult for peop...
Status
Recruiting
Location
113 Suicide Prevention
Start Date
2024-05-07
Trial ID
NCT06370104
Treatments Being Tested
This study intends to demonstrate bioequivalence of two formulations, the e...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-07
Trial ID
NCT00449774
Treatments Being Tested
This study is divided in 2 parts. Part 1a is being conducted to evaluate th...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-04
Trial ID
NCT02853435
Treatments Being Tested
The objective of this study is to demonstrate bioequivalence of 4 mg tablet...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-01
Trial ID
NCT00786240
Treatments Being Tested
AD17002 enhances nasal mucosal innate immunity and has met safety and effic...
Status
Terminated
Location
RSPI Sulianti Saroso
Start Date
2022-12-01
Trial ID
NCT05541510
Treatments Being Tested